GB Sciences, Inc. (GBLX)
0.0001
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
GB Sciences Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | -0.1004M |
| September 30, 2024 | -0.1905M |
| June 30, 2024 | -0.285M |
| March 31, 2024 | -0.467M |
| December 31, 2023 | -0.1873M |
| September 30, 2023 | -0.4342M |
| June 30, 2023 | -0.2731M |
| March 31, 2023 | -2.865M |
| December 31, 2022 | -0.4488M |
| September 30, 2022 | -0.3131M |
| June 30, 2022 | -0.4981M |
| March 31, 2022 | -3.608M |
| December 31, 2021 | 4.518M |
| September 30, 2021 | -0.4978M |
| June 30, 2021 | -0.5587M |
| March 31, 2021 | -0.0892M |
| December 31, 2020 | -0.6296M |
| September 30, 2020 | -0.9235M |
| June 30, 2020 | -1.475M |
| March 31, 2020 | -3.626M |
| December 31, 2019 | 2.532M |
| September 30, 2019 | -1.494M |
| June 30, 2019 | -2.539M |
| March 31, 2019 | -4.717M |
| December 31, 2018 | -3.462M |
| Date | Value |
|---|---|
| September 30, 2018 | -9.205M |
| June 30, 2018 | -5.352M |
| March 31, 2018 | -9.896M |
| December 31, 2017 | -6.962M |
| September 30, 2017 | -3.179M |
| June 30, 2017 | -3.117M |
| March 31, 2017 | -2.617M |
| December 31, 2016 | -3.581M |
| September 30, 2016 | -2.506M |
| June 30, 2016 | -1.379M |
| March 31, 2016 | -1.697M |
| December 31, 2015 | -1.155M |
| September 30, 2015 | -2.705M |
| June 30, 2015 | -1.522M |
| March 31, 2015 | -4.021M |
| December 31, 2014 | -0.678M |
| September 30, 2014 | -1.78M |
| June 30, 2014 | -1.495M |
| March 31, 2014 | -0.7047M |
| December 31, 2013 | -0.183M |
| September 30, 2013 | 0.274M |
| June 30, 2013 | -0.0422M |
| March 31, 2013 | -0.3573M |
| December 31, 2012 | 0.09M |
| September 30, 2012 | -0.0311M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Bio-Path Holdings, Inc. | -2.636M |
| Arvinas, Inc. | 169.40M |
| Kaleido Biosciences, Inc. | -- |